WRLD

Search

#Sanofi
Frankfurter Allgemeine 2d

Sanofi plans to build a new insulin factory in Frankfurt to continue the more than 100-year tradition of insulin production at the site and to meet the increasing demand for diabetes medications. #Insulinproduktion #Diabetesmedikamente #Sanofi (translated)

www.faz.net
Diabetesmedikamente: Wie in Frankfurt eine der größten Insulinproduktionen der Welt entstand
3220
Le Monde.fr 4d

Sanofi has been urged by the EU to rectify its communication after being accused of disparaging a competitor in the context of flu vaccines. #ErroresDeConexión #NavegaciónWeb #SoluciónDeProblemas (translated)

www.lemonde.fr
Vaccins contre la grippe : Sanofi, accusé d’avoir dénigré un concurrent, sommé par l’UE de rectifier sa communication
2699
EL PAÍS 5d

Sanofi has committed to the European Commission to correct its advertising for the Fluad vaccine to avoid sanctions for possible misleading practices compared to its product Efluelda. #Sanofi #Vacunas #CompetenciaEU (translated)

elpais.com
Sanofi se compromete ante la UE a corregir sus mensajes sobre una vacuna rival contra la gripe para evitar una multa
3270
Ekaterina Zaharieva 5d

The author said the future of AI was in scientists’ hands and that the best companies relied on Europe. They said they were pleased to meet the CEOs of DeepL, Nuritas, Google DeepMind, Analog Devices and Sanofi and to see their support for the Commission’s AI in Science initiative. https://t.co/XCGW9UIJtb #AI #Innovation #Science #EU

2932
BFMTV 5d

Sanofi escaped a colossal fine from Brussels for being suspected of disparaging the Fluad flu vaccine in favor of its own product Efluelda, committing to rectify its communications and to cease any negative representation of its competitor. #Sanofi #Vaccin #CommissionEuropéenne (translated)

www.bfmtv.com
Sanofi était soupçonné de dénigrer un vaccin antigrippal d'une entreprise rivale: le géant pharmaceutique échappe à une amende colossale de Bruxelles en échange d'engagements
2935
Teresa Ribera 5d

At the beginning of autumn, millions of patients and healthcare professionals in the EU prepare for the flu vaccination campaign. Today's decision ensures that they can choose their vaccine based on an impartial assessment of the scientific evidence. When large pharmaceutical companies in a dominant position spread false or misleading information about competing vaccines, they distort competition and undermine the freedom of choice for doctors and patients. Teresa Ribera, Executive Vice President of the European Commission for Competition, stated this Wednesday that "at the beginning of autumn, millions of patients and healthcare professionals in the EU prepare for the flu vaccination campaign. Today's decision ensures that they can choose their vaccine based on an impartial assessment of the scientific evidence. When large pharmaceutical companies in a dominant position spread false or misleading information about competing vaccines, they distort competition and undermine the freedom of choice for doctors and patients." #Sanofi #vacunas #competencia (translated)

Bruselas tuerce el brazo a Sanofi para que acabe con la campaña de engaños contra otro fabricante de vacunas de la gripe
www.eldiario.es
3499
eldiario.es 5d

Brussels has forced Sanofi to cease a disinformation campaign against the Fluad flu vaccine, after suspecting that the French multinational was trying to dominate the high-dose vaccine market in Germany and France through deceptive tactics. #Sanofi #vacunas #competencia (translated)

www.eldiario.es
Bruselas tuerce el brazo a Sanofi para que acabe con la campaña de engaños contra otro fabricante de vacunas de la gripe
3499
Belén Garijo 1w

It has been a surprise even for me, because I had decided, before starting talks with Sanofi, that perhaps the time had come to start a non-executive or less executive phase. Garijo acknowledges to Actualidad Económica that this new role "has been a surprise even for me, because I had decided, before starting talks with Sanofi, that perhaps the time had come to start a non-executive or less executive phase." #Sanofi #InnovaciónSanitaria #IndustriaFarmacéutica (translated)

El aviso de Belén Garijo, la española al frente del gigante Sanofi: "El futuro se construye aquí, o en otro lugar"
www.elmundo.es
2959
E
EL MUNDO 1w

Belén Garijo, the new CEO of Sanofi, warns about the need for Europe to reinforce its commitment to healthcare innovation in order not to lose competitiveness against the United States and China, while she aims to write a new story for the company focusing on the identification of medicines that address critical medical needs. #Sanofi #InnovaciónSanitaria #IndustriaFarmacéutica (translated)

www.elmundo.es
El aviso de Belén Garijo, la española al frente del gigante Sanofi: "El futuro se construye aquí, o en otro lugar"
2959
Guillaume Herblot 🎖️ 2w

I present to you the inhumane conditions of the Doctor Charles Mérieux high school in Lyon. Light concrete atrium, wooden stairs, giant screens flashing hearts, levels A2, A3, A4 like in a corporate headquarters, work alcoves, bleachers facing the windows, yellow chairs, design false ceilings. The former Sanofi-Pasteur building, bought and remodeled for "the high school of tomorrow." You can immediately feel the misery. On September 14, the peak of indignity: a fire broke out in the 4th floor bathrooms. Excessive reaction, no doubt, in the face of the oppression of the wooden bleachers and overly bright alcoves. Who are you seriously making fun of? #Lycée #ConditionsInhumaines #Lyon (translated)

13491
BFMTV 3w

Sanofi announces an investment of at least one billion dollars in collaboration with Regeneron to develop new antibodies, aimed at succeeding the commercial success of Dupixent, whose global sales reached 15.7 billion euros in 2025. #Sanofi #Regeneron #Dupixent (translated)

www.bfmtv.com
Après le jackpot Dupixent à 15,7 milliards d'euros, Sanofi mise jusqu'à 8 milliards de dollars avec Regeneron pour trouver son prochain blockbuster
1500
L
Le Soir 3w

Sanofi will pay one billion dollars to Regeneron for the development of antibodies competing with Dupixent, its flagship drug that will lose exclusivity in the 2030s. #Sanofi #Regeneron #Dupixent (translated)

www.lesoir.be
Sanofi verse un milliard à l'états-unien Regeneron pour la relève du médicament vedette
1385
L
Le Soir Sep 9

La Commission européenne a approuvé une subvention de 400 millions d'euros de l'Allemagne à Sanofi pour garantir l'approvisionnement en insuline en Europe, en maintenant son site de production à Francfort et en évitant ainsi la dépendance aux importations extérieures. #Sanofi #Insuline #SoutienPublic

www.lesoir.be
Feu vert UE à une subvention de 400 millions à Sanofi pour l’approvisionnement en insuline
16967
Piotr Witczak Aug 9

Co łączy naukowców głośno popierających ustawę Lex Big Pharma? Totalitaryzm medyczny i współpraca z przemysłem farmaceutycznym Prof. Banach: 👉"Nie wyobrażam sobie (...) by ta ustawa [Lex Big Pharma] (...) nie weszła w życie" [1] 👉"lockdowny nie powinny obejmować osób zaszczepionych przeciwko COVID-19. Restrykcjom związanym z ograniczonym przemieszczaniem się powinno poddawać tylko niezaszczepionych" [2] 👉"4 dawka przyjęta. Nie czekaj, zaszczep się" [zdjęcie] 👉Konflikt interesu: wynagrodzenia od m. in. Amgen, Novartis, Novo Nordisk, Sanofi [3] Prof. Szuster-Ciesielska: 👉"Jednym z najmocniejszych głosów poparcia dla ustawy jest list otwarty prof. Agnieszki Szuster-Ciesielskiej" [4] 👉"Mam nadzieję, że niedługo nie będzie tego miesięcznika ["Zdrowie bez leków"] [5] 👉"Szczepionki p/HPV powinny być obowiązkowe” [6] 👉"Dzisiaj zaszalałam, zaszczepiłam się na dwie ręce" [zdjęcie] 👉Konflikt interesu: występowanie na wydarzeniach organizowanych przez MSD - firma produkującą szczepionkę HPV [7,8] 1 https://t.co/tnBodd63ce 2 https://t.co/1IJopw0lje 3 https://t.co/kJpkEckumQ 4 https://t.co/2NH2jXiWao 5 https://t.co/23M007DrqK 6 https://t.co/MDuqH9Vca7 7 https://t.co/YlBFlxx7fC 8 https://t.co/zAHh8x3kBU #LexBigPharma #Zdrowie #Szczepionki

14768
Dr. Jonas Toegel Jul 9

Wie inszeniert man eine Pandemie? Bis heute wissen die meisten Menschen nicht, wie gezielt die psychologischen Botschaften während der Corona-Zeit geplant und gesteuert wurden. Ein besonders eklatantes Beispiel dafür ist dieser Vortrag des belgischen Mikrobiologen Marc Van Ranst aus dem Jahr 2019. Van Ranst erklärt darin nicht nur, wie man mit fiktiven Hochrechnungen zu (alljährlich üblichen) Sterbezahlen der Grippe eine Panik inszenieren kann. Er warnt auch explizit vor dem deutschen Experten und Arzt Wolfgang @wodarg, der die Schweinegrippe im Jahr 2009 als Pharmabetrug entlarvte und ab 2020 folgerichtig frühzeitig vor der unbegründeten Panikmache während Corona warnte. Obschon sich viele von Wodargs Aussagen später als richtig herausstellten, wurde er massiv angegriffen und als "Verschwörungstheoretiker" diffamiert. Besonders interessant sind die Interessenskonflikte von Marc Van Ranst: Er ist im Beirat bzw. hielt Vorträge für zahlreiche große Pharmakonzerne wie Glaxo-Smith-Klein, Merck, Johnson&Johnson, Sanofi-Pasteur, u.v.m. Folgen Sie mir auf Telegram: https://t.co/wC1x0C7toA #Pandemie #Psychologie #Gesundheit

15215
Stefan Homburg Jul 4

@NikolausBlome Klickt man bis zur Quelle, erhält man einen Werbeartikel von Imperial College u.a., ohne eigenes Forschungsergebnis und finanziert durch Moderna, Pfizer, Sanofi, Merck ... https://t.co/UOp5xMt8OS #Forschung #Medizin #Pharma

952
BFMTV Jun 28

Charles Wolf, directeur général de Sanofi, met en garde contre le déclin de la production de nouveaux médicaments en France par rapport à d'autres pays, appelant à une stratégie industrielle à long terme pour restaurer l'attractivité du secteur pharmaceutique français, qui ne contribue plus qu'à 9 % des produits validés par l'Europe, contre 24 % pour l'Allemagne. #industriepharmaceutique #Sanofi #productionmédicaments

www.bfmtv.com
"Les nouveaux médicaments sont beaucoup moins produits en France qu'avant": le directeur général de Sanofi appelle à "réagir pour redevenir une puissance" de l'industrie pharmaceutique
12502
Dnevnik Jun 26

Sanofi čelí prešetrovaniu zo strany Bruselu kvôli kontroverznej propagácii svojho vakcíny proti chrípke, zatiaľ čo ďalšie farmaceutické firmy ako Bayer a Johnson & Johnson sú zasa na očiach verejnosti kvôli miliardovým odškodneniam za výrobky spôsobujúce rakovinu. #odškodnine #rak #Bayer

www.dnevnik.si
Sanofi pod drobnogledom Bruslja zaradi promocije cepiva proti gripi
13697
Franceinfo Jun 26

La Commission européenne a ouvert une enquête contre Sanofi, suspectant le géant pharmaceutique d'entrave à la concurrence sur le marché des vaccins antigrippaux en menant une campagne de dénigrement contre le vaccin Fluad de CSL Seqirus, ce qui pourrait entraîner des sanctions pour abus de position dominante. #Sanofi #Vaccins #Concurrence

www.franceinfo.fr
L'Union européenne ouvre une enquête contre Sanofi, soupçonné d'entrave à la concurrence sur le marché des vaccins antigrippaux
11315
Observador Jun 26

A Comissão Europeia iniciou uma investigação formal à Sanofi por suspeita de abuso de posição dominante no mercado da vacina contra a gripe, após alegações de que a farmacêutica teria desacreditado uma concorrente, a Fluad, em campanhas dirigidas a profissionais de saúde na Alemanha e França. #Vacinas #Saúde #UE

observador.pt
Vacinas. UE investiga Sanofi por abuso de posição dominante
16079